吕嬿;冯凤芝;向阳;万希润;
Lü Yan;FENG Feng-zhi;XIANG Yang;WAN Xi-run;Department of Obstetrics and Gynecology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院妇产科

摘要(Abstract)：

目的探讨持续性真性低水平人绒毛膜促性腺激素(human chorionic gonadotropin,h CG)升高患者的临床特点和诊治意义。方法 2011年8月至2015年3月北京协和医院诊断为持续性真性低水平h CG升高患者6例,收集患者临床资料,对疾病特点、诊治过程和随诊情况进行回顾性分析。结果 6例患者中,3例继发于葡萄胎清宫术后,3例继发于侵蚀性葡萄胎化疗后。3例侵蚀性葡萄胎患者的中位总疗程数为8个,均有化疗失败史。6例患者随诊中位时间为24个月,自治疗结束至h CG呈低水平升高的中位时间为5.5个月,低水平h CG升高持续的中位时间为16.5个月。4例患者病情稳定,1例进展为绒毛膜癌,1例自然妊娠分娩后h CG降至正常。结论持续性真性低水平h CG升高的持续时间较长,对化疗不敏感,应密切随诊,不宜治疗。
Objective To investigate the clinical characteristics and significance of diagnosis and treatment associated with persistent real low-level elevation of human chorionic gonadotropin( h CG). Methods Six patients diagnosed with persistent real low-level h CG elevation at Peking Union Medical College Hospital in the period from August 2011 to March 2015 were collected. Clinical records of the 6 patients were reviewed to retrospectively analyze clinical features,diagnosis and treatment approaches,and follow-up results. Results Among the 6 patients,3 were secondary to uterine curettage for hydatidiform moles,and the other 3 had received chemotherapy for invasive moles,in whom the median chemotherapy cycle number was 8 and all experienced failure of at least one chemotherapy regimen. The median follow-up time was 24 months. The median period between the termination of treatment and the initial low-level h CG elevation was 5. 5 months. The median duration of low-level h CG elevation was 16. 5 months. Four patients had no evidence of progression,1 patient progressed to choriocarcinoma,and 1 presented with the h CG level decreasing to the normal range after spontaneous delivery. Conclusion Persistent real low-level h CG elevation may persist for a long time and not respond to chemotherapy. Longterm close monitoring is necessary,but treatment is not recommended.

关键词(KeyWords)： 人绒毛膜促性腺激素;妊娠滋养细胞疾病;化疗
human chorionic gonadotropin;gestational trophoblastic disease;chemotherapy

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 吕嬿;冯凤芝;向阳;万希润;
Lü Yan;FENG Feng-zhi;XIANG Yang;WAN Xi-run;Department of Obstetrics and Gynecology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

参考文献(References)：

• [1]Khanlian SA,Smith HO,Cole LA.Persistent low levels of human chorionic gonadotropin:A premalignant gestational trophoblastic disease[J].Am J Obstet Gynecol,2003,188:1254-1259.
• [2]Kohorn EI.What we know about low-level h CG:definition,classification and management[J].J Reprod Med,2004,49:433-437.
• [3]Kohorn EI.Persistent low-level“real”human chorionic gonadotropin:a clinical challenge and a therapeutic dilemma[J].Gynecol Oncol,2002,85:315-320.
• [4]Cole LA,Khanlian SA.Inappropriate management of women with persistent low h CG results[J].J Reprod Med,2004,49:423-432.
• [5]钱学茜,万小云.持续性低水平HCG升高的诊治[J].现代妇产科进展,2011,20:3-4,7.
• [6]Cole LA,Butler SA,Khanlian SA,et al.Gestational trophoblastic diseases:2.Hyperglycosylated h CG as a reliable marker of active neoplasia[J].Gynecol Oncol,2006,102:151-159.
• [7]侯进琳,万希润,杨秀玉.持续性低水平人绒毛膜促性腺激素升高的临床意义[J].中华妇产科杂志,2006,41:785-786.
• [8]Cole LA.Hyperglycosylated h CG,a review[J].Placenta,2010,31:653-664.
• [9]Hwang D,Hancock BW.Management of persistent,unexplained,low-level human chorionic gonadotropin elevation:a report of 5 cases[J].J Reprod Med,2004,49:559-562.
• [10]Boafo-Yirenki M,Everard J,Tidy J,et al.A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia[J].J Reprod Med,2009,54:288-290.